+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Dengue Testing - Global Market Trajectory & Analytics

  • ID: 5028025
  • Report
  • April 2021
  • Region: Global
  • 281 Pages
  • Global Industry Analysts, Inc
Global Dengue Testing Market to Reach $709.6 Million by 2027

Amid the COVID-19 crisis, the global market for Dengue Testing estimated at US$496.1 Million in the year 2020, is projected to reach a revised size of US$709.6 Million by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027. ELISA-Based Tests, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$353.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RT-PCR Based Tests segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $134.4 Million, While China is Forecast to Grow at 8.1% CAGR

The Dengue Testing market in the U.S. is estimated at US$134.4 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$147.5 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Dengue IgG/IgM Rapid Test Segment to Record 4.6% CAGR

In the global Dengue IgG/IgM Rapid Test segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$44.4 Million in the year 2020 will reach a projected size of US$59.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$94.8 Million by the year 2027, while Latin America will expand at a 5.6% CAGR through the analysis period.

Select Competitors (Total 41 Featured):
  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec S.L.
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.
Frequently Asked Questions about the Global Market for Dengue Testing

What is the estimated value of the Global Market for Dengue Testing?

The Global Market for Dengue Testing was estimated to be valued at $496.1 Million in 2020.

What is the growth rate of the Global Market for Dengue Testing?

The growth rate of the Global Market for Dengue Testing is 5.2%, with an estimated value of $709.6 Million by 2027.

What is the forecasted size of the Global Market for Dengue Testing?

The Global Market for Dengue Testing is estimated to be worth $709.6 Million by 2027.
Note: Product cover images may vary from those shown

  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession


  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown